Skip to main content
Top

International Cancer Conference Journal

Issue 3/2019

Content (10 Articles)

Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma

Akihiro Tamura, Nobuyuki Yamamoto, Nanako Nino, Takayuki Ichikawa, Naoko Nakatani, Sayaka Nakamura, Atsuro Saito, Aiko Kozaki, Kenji Kishimoto, Toshiaki Ishida, Makiko Yoshida, Yoshinobu Akasaka, Daiichiro Hasegawa, Yoshiyuki Kosaka

Successful treatment of advanced gastric cancer with liver metastasis by S-1 + CDDP and S-1 therapy without surgery

Yuichiro Tanishima, Yuya Nyumura, Tomoko Nakayoshi, Yoshiyuki Hoya, Tomoyoshi Okamoto, Katsuhiko Yanaga

Hematogenous intestinal metastases from sigmoid colon cancer presenting as iliopsoas abscess and bowel obstruction

Harunobu Sato, Susumu Shibasaki, Asako Okabe, Tetsuya Tsukamoto, Zenichi Morise, Ichiro Uyama

Open Access Metastasis Case report

Small-cell lung carcinoma with ovarian metastasis 4 years after the first-line treatment

Jun Kitazawa, Akimasa Takahashi, Mao Uemura, Yoshihiko Hayashi

NSCLC Case report

Simultaneous chylous ascites and chylothorax during ramucirumab plus docetaxel chemotherapy in a patient with non-small lung cell cancer

Makoto Arai, Susumu Maruta, Meng Meng Fan, Chiaki Imai, Akinobu Tawada, Yuichi Takiguchi

Primary small cell neuroendocrine carcinoma of adrenal gland

Kosuke Ogawa, Yousuke Shimizu, Shoko Uketa, Noriaki Utsunomiya, Kazutaka Kida, Misa Ishihara, Kimio Hashimoto, Sojun Kanamaru

Stroke Case report

Cancer-associated cerebral infarction during direct oral anticoagulant treatment in cancer patients: a case series

Takuya Oyakawa, Hiroyuki Fukuda, Nao Muraoka, Kei Iida, Masatoshi Kusuhara

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine